title

Talking About Glaucoma (TAG) AAC - WholeLottaRob

Robert M Schertzer, MD, MEd, FRCSC

0
Followers
0
Plays
Talking About Glaucoma (TAG) AAC - WholeLottaRob
Talking About Glaucoma (TAG) AAC - WholeLottaRob

Talking About Glaucoma (TAG) AAC - WholeLottaRob

Robert M Schertzer, MD, MEd, FRCSC

0
Followers
0
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

The MP3 version lacks enhanced content found on the full (AAC) version but works on legacy devices.

Latest Episodes

LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

The goal of the late Dave Epstein was to find adrug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of trying, AeriePharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals.

12 MINJUN 7
Comments
LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

Talking About Glaucoma #30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

In this episode, I talk with Murray Johnstone from Seattle about pulsatile flow through the Trabecular Meshwork and collector channels. We discuss the imaging improvements over the years that have made this possible including the latest phase-based OCT scans that result in nanometre resolution instead of the micrometre resolution of spectral domain scans that most of us are using in clinical practice.

35 MIN2018 NOV 6
Comments
Talking About Glaucoma #30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

Talking About Glaucoma #29 - 29Jan2018 FELLMAN Fluid Wave (AAC)

I sat down with Ron Fellman at a recent American Glaucoma Society meeting to discuss the use of the fluid wave in assessing the aqueous humour outflow pathway and its clinical application.

19 MIN2018 JAN 29
Comments
Talking About Glaucoma #29 - 29Jan2018 FELLMAN Fluid Wave (AAC)

Latest Episodes

LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

The goal of the late Dave Epstein was to find adrug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of trying, AeriePharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals.

12 MINJUN 7
Comments
LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (AAC)

Talking About Glaucoma #30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

In this episode, I talk with Murray Johnstone from Seattle about pulsatile flow through the Trabecular Meshwork and collector channels. We discuss the imaging improvements over the years that have made this possible including the latest phase-based OCT scans that result in nanometre resolution instead of the micrometre resolution of spectral domain scans that most of us are using in clinical practice.

35 MIN2018 NOV 6
Comments
Talking About Glaucoma #30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (AAC)

Talking About Glaucoma #29 - 29Jan2018 FELLMAN Fluid Wave (AAC)

I sat down with Ron Fellman at a recent American Glaucoma Society meeting to discuss the use of the fluid wave in assessing the aqueous humour outflow pathway and its clinical application.

19 MIN2018 JAN 29
Comments
Talking About Glaucoma #29 - 29Jan2018 FELLMAN Fluid Wave (AAC)

Listen Now On Himalaya